Building BRICs: Pharma’s Key Emerging Markets Are Becoming Giants

The BRIC nations — Brazil, India, Russia and China — should no longer be classified as developing pharmaceutical markets, as their markets are not very different in size from the traditional “Western” pharmaceutical markets.
PMLive